Acute Biphenotypic Leukemia (ABL) Recruiting Phase 2 Trials for Antithymocyte immunoglobulin (rabbit) (DB00098)

Also known as: Acute biphenotypic leukaemia / Acute Biphenotypic Leukemia / Leukemia, Biphenotypic, Acute / Acute bilineal leukemia

IndicationStatusPhase
DBCOND0081399 (Acute Biphenotypic Leukemia (ABL))Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03970096Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute LeukemiaTreatment